Shilajit Extract: Examining Biomedical Applications—A Systematic Review Protocol

Background: Shilajit, a natural mineral exudate utilized for centuries in traditional Ayurvedic and Eastern European medicine, is regarded as a traditional adaptogenic substance and rejuvenator. This systematic review synthesizes contemporary scientific evidence regarding the biomedical applications of Shilajit extract, critically evaluating its pharmacological properties and therapeutic potential. Methods: A systematic search was performed across PubMed, Scopus, Web of Science, and the Cochrane Library for peer-reviewed literature published between 1951 and 2026. Studies were screened against rigorous eligibility criteria, and methodological quality was appraised using the Cochrane Risk of Bias 2.0 and SYRCLE tools. Results: Studies were included in the final analysis. Characterized by high concentrations of fulvic acid and dibenzo-α-pyrones, Shilajit exhibits antioxidant activity, anti-inflammatory, neuroprotective, and adaptogenic activities. Preclinical data demonstrate dose-dependent cytotoxicity against multiple cancer cell lines via apoptosis induction. Furthermore, evidence suggests its efficacy in enhancing muscular strength, improving reproductive function, and mitigating protein aggregation in neurodegenerative contexts. Conclusions: Shilajit possesses significant biomedical potential that aligns with its traditional applications. However, clinical integration requires addressing standardization challenges, implementing stringent quality control to mitigate heavy metal risks, and conducting large-scale human trials to definitively establish safety and efficacy profiles.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-13
DOI
https://doi.org/10.3390/ph19111802
Primary Topic
Humic Substances and Bio-Organic Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Shilajit Extract: Examining Biomedical Applications—A Systematic Review Protocol

Svіtlana Zahorodnia, Lucía Margarita Valenzuela-Salas, Nenad Janković, Ricardo Valdez et al.
3 links
Pharmaceuticals
Humic Substances and Bio-Organic Studies
article

Shilajit Extract: Examining Biomedical Applications—A Systematic Review Protocol

Svіtlana Zahorodnia, Lucía Margarita Valenzuela-Salas, Nenad Janković, Ricardo Valdez, Graciela Lizeth Pérez-González, Nodari Rizun, Luis Jesús Villarreal-Gómez, Angélica Garzón-Fontecha, Carlos Rodríguez-Escobar
article en

Abstract

Background: Shilajit, a natural mineral exudate utilized for centuries in traditional Ayurvedic and Eastern European medicine, is regarded as a traditional adaptogenic substance and rejuvenator. This systematic review synthesizes contemporary scientific evidence regarding the biomedical applications of Shilajit extract, critically evaluating its pharmacological properties and therapeutic potential. Methods: A systematic search was performed across PubMed, Scopus, Web of Science, and the Cochrane Library for peer-reviewed literature published between 1951 and 2026. Studies were screened against rigorous eligibility criteria, and methodological quality was appraised using the Cochrane Risk of Bias 2.0 and SYRCLE tools. Results: Studies were included in the final analysis. Characterized by high concentrations of fulvic acid and dibenzo-α-pyrones, Shilajit exhibits antioxidant activity, anti-inflammatory, neuroprotective, and adaptogenic activities. Preclinical data demonstrate dose-dependent cytotoxicity against multiple cancer cell lines via apoptosis induction. Furthermore, evidence suggests its efficacy in enhancing muscular strength, improving reproductive function, and mitigating protein aggregation in neurodegenerative contexts. Conclusions: Shilajit possesses significant biomedical potential that aligns with its traditional applications. However, clinical integration requires addressing standardization challenges, implementing stringent quality control to mitigate heavy metal risks, and conducting large-scale human trials to definitively establish safety and efficacy profiles.

PharmaceuticalsVol. 19(11)
University of Kragujevac (RS), Universidad Autónoma de Baja California (MX), Tecnológico Nacional de México (MX), Instituto Tecnológico de Tijuana (MX), Danylo Zabolotny Institute of Microbiology and Virology (UA), Institute for Information Technologies Kragujevac (RS)
Good health and well-being
Humic Substances and Bio-Organic Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon